Article ID Journal Published Year Pages File Type
10897386 Cancer Epidemiology 2013 5 Pages PDF
Abstract
Rosiglitazone does not increase the risk of bladder cancer.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Rosiglitazone is not associated with an increased risk of bladder cancer
Authors
,